AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 66 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $147,000 | +21.5% | 163,225 | 0.0% | 0.00% | – |
| Q3 2016 | $121,000 | -42.7% | 163,225 | 0.0% | 0.00% | – |
| Q2 2016 | $211,000 | +1141.2% | 163,225 | +2037.0% | 0.00% | – |
| Q1 2016 | $17,000 | -37.0% | 7,638 | 0.0% | 0.00% | – |
| Q4 2015 | $27,000 | +28.6% | 7,638 | +3.6% | 0.00% | – |
| Q3 2015 | $21,000 | +23.5% | 7,374 | 0.0% | 0.00% | – |
| Q2 2015 | $17,000 | -98.1% | 7,374 | -93.9% | 0.00% | -100.0% |
| Q1 2015 | $908,000 | +116.2% | 120,605 | -1.5% | 0.00% | 0.0% |
| Q4 2014 | $420,000 | -2.6% | 122,406 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $431,000 | -56.4% | 121,969 | +2.9% | 0.00% | 0.0% |
| Q2 2014 | $989,000 | +48.1% | 118,475 | +12.7% | 0.00% | 0.0% |
| Q1 2014 | $668,000 | +9.2% | 105,131 | +22.4% | 0.00% | 0.0% |
| Q4 2013 | $612,000 | +3.2% | 85,877 | +8.6% | 0.00% | 0.0% |
| Q3 2013 | $593,000 | +41.5% | 79,047 | +8.7% | 0.00% | 0.0% |
| Q2 2013 | $419,000 | – | 72,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |